This meeting is an annual gathering of biostatisticians interested in using Bayesian methods in life science and public health settings. A particular focus of the meeting is biopharmaceutical development, with associated discussion of methods acceptable in regulatory science. The meeting begins with a free half-day short course, then 8 plenary speakers (30 mins) and a large number of contributed talks (20 mins). The 2026 meeting features invited speakers from both FDA & EMA, and a panel discussion focused on the various Bayesian guidance documents currently emerging from these agencies.